CytoDyn Inc. P/S Ratio
The price-to-sales (P/S) ratio tells you how many dollars investors pay for each dollar of a company's annual revenue. It is market capitalization divided by revenue over the trailing four quarters, meaning the four most recent filed quarters added together, and the table shows both amounts. A higher P/S means investors are paying more for each dollar of sales; because revenue is rarely negative, the ratio stays usable for companies that are not yet profitable. Each point uses the filed share count and the last closing price on or before that quarter-end date, never today's price.
- CytoDyn Inc. p/s ratio for the quarter ending 2022-05-31 was 865.67.
- CytoDyn Inc. p/s ratio for the quarter ending 2022-02-28 was 1,367.58.
- CytoDyn Inc. p/s ratio for the quarter ending 2021-11-30 was 3,220.95.
- CytoDyn Inc. p/s ratio for the quarter ending 2021-08-31 was 21,665.23.
- CytoDyn Inc. p/s ratio for fiscal 2022 was 865.67.
- CytoDyn Inc. p/s ratio for fiscal 2021 was 3,220.95.
- Available history
- 2021-08-31 to 2022-05-31
- Data captured